These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39209505)

  • 1. Influence of stage and age on survival of patients with vulvar cancer in Germany: a retrospective study.
    Mack LC; Hagemeier A; Forner DM
    BMJ Open; 2024 Aug; 14(8):e077960. PubMed ID: 39209505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL
    Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
    Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
    Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis.
    Zhou J; Shan G
    Curr Med Res Opin; 2016 Jun; 32(6):1121-30. PubMed ID: 26959073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
    Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
    Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer.
    Tantipalakorn C; Robertson G; Marsden DE; Gebski V; Hacker NF
    Obstet Gynecol; 2009 Apr; 113(4):895-901. PubMed ID: 19305336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer.
    Sznurkowski JJ; Milczek T; Emerich J
    Arch Gynecol Obstet; 2013 Jun; 287(6):1211-8. PubMed ID: 23263173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system?
    Thaker NG; Klopp AH; Jhingran A; Frumovitz M; Iyer RB; Eifel PJ
    Gynecol Oncol; 2015 Feb; 136(2):269-73. PubMed ID: 25524458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
    Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system.
    Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA
    Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
    Yuan GW; Li XG; Li N; Yao HW; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
    Klapdor R; Hillemanns P; Wölber L; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Habermann A; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Meier W; Harter P; Wimberger P; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Jäger M; Mahner S
    Ann Surg Oncol; 2017 May; 24(5):1314-1321. PubMed ID: 27896515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
    Fonseca-Moutinho JA; Coelho MC; Silva DP
    J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study).
    Homesley HD; Bundy BN; Sedlis A; Yordan E; Berek JS; Jahshan A; Mortel R
    Am J Obstet Gynecol; 1991 Apr; 164(4):997-1003; discussion 1003-4. PubMed ID: 2014852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging for vulvar cancer.
    Hacker NF; Barlow EL
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):802-11. PubMed ID: 25842047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A suggested modification to FIGO stage III vulvar cancer.
    Rouzier R; Preti M; Sideri M; Paniel BJ; Jones RW
    Gynecol Oncol; 2008 Jul; 110(1):83-6. PubMed ID: 18436291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the 2021 FIGO staging schema for advanced vulvar cancer.
    Matsuo K; Klar M; Nishio S; Mikami M; Roman LD; Wright JD
    Int J Gynecol Cancer; 2022 Apr; 32(4):474-479. PubMed ID: 34996835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.